Eton Pharmaceuticals IncETON
Price$51.98Intrinsic value$21.6958% below price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
Analyst Coverage
4analysts covering
Consensus: PositiveAs of 18 Aug 2026
FY Revenue (est.)
$149.7Mnext fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Product Sales and Royalty Revenue Quarterly24.3MTarget: Exceed $120 million for full year 2026
Adjusted EBITDA Margin AnnuallyTarget: At least 30% for full year 2026; 50% by 2028
Watch Items
  • KHINDIVI label expansion supplement filing
  • ET-700 clinical study readout
Sign in / Sign up to read more

Research as of 19 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.